{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T01:28:08Z","timestamp":1711070888777},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,21]]},"DOI":"10.7759\/cureus.56615","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:08:05Z","timestamp":1711012085000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatic Tumor Rupture in Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders of the B-cell Type in a Patient With Chronic Rheumatoid Arthritis"],"prefix":"10.7759","author":[{"given":"Kazuto","family":"Togitani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sakaeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn LH","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021, 384:842-58. 10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04749.x","article-title":"Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases","volume":"124","author":"M\u00f8ller MB","year":"2004","unstructured":"M\u00f8ller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases. Br J Haematol. 2004, 124:151-9. 10.1046\/j.1365-2141.2003.04749.x","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03205-x","article-title":"Diagnostic approach in hepatic lymphoma: radiological imaging findings and literature review","volume":"146","author":"Ippolito D","year":"2020","unstructured":"Ippolito D, Porta M, Maino C, et al.. Diagnostic approach in hepatic lymphoma: radiological imaging findings and literature review. J Cancer Res Clin Oncol. 2020, 146:1545-58. 10.1007\/s00432-020-03205-x","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2018.04.002","article-title":"Rupture of hepatocellular carcinoma: a review of literature","volume":"9","author":"Sahu SK","year":"2019","unstructured":"Sahu SK, Chawla YK, Dhiman RK, et al.. Rupture of hepatocellular carcinoma: a review of literature. J Clin Exp Hepatol. 2019, 9:245-56. 10.1016\/j.jceh.2018.04.002","journal-title":"J Clin Exp Hepatol"},{"key":"ref5","article-title":"Hepatic tumor rupture following effectual treatment with irinotecan in a patient with highly refractory malignant lymphoma","volume":"70","author":"Tsutani H","year":"1999","unstructured":"Tsutani H, Inai K, Kishi S, Morinaga K, Naiki H, Ueda T. Hepatic tumor rupture following effectual treatment with irinotecan in a patient with highly refractory malignant lymphoma. Int J Hematol. 1999, 70:178-80.","journal-title":"Int J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-018-0451-2","article-title":"A rare case of a spontaneously ruptured secondary hepatic malignant lymphoma","volume":"4","author":"Oshita K","year":"2018","unstructured":"Oshita K, Itamoto T, Oshita A, Nakahara H, Nishisaka T. A rare case of a spontaneously ruptured secondary hepatic malignant lymphoma. Surg Case Rep. 2018, 4:44. 10.1186\/s40792-018-0451-2","journal-title":"Surg Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.63.211","article-title":"[Rupture of hepatic lesion of diffuse large B-cell lymphoma following immunochemotherapy]","volume":"63","author":"Segawa R","year":"2022","unstructured":"Segawa R, Natazuka T. [Rupture of hepatic lesion of diffuse large B-cell lymphoma following immunochemotherapy]. Rinsho Ketsueki. 2022, 63:211-6. 10.11406\/rinketsu.63.211","journal-title":"Rinsho Ketsueki"},{"key":"ref8","article-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, et al. (ed): IARC, Press, Lyon, France; 2008."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa A","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, et al.. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013, 91:20-8. 10.1111\/ejh.12116","journal-title":"Eur J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14740\/jmc4135","article-title":"Primary hepatic other iatrogenic immunodeficiency-associated lymphoproliferative disorders after methotrexate therapy","volume":"14","author":"Hatayama Y","year":"2023","unstructured":"Hatayama Y, Sugiyama H, Murakami D, et al.. Primary hepatic other iatrogenic immunodeficiency-associated lymphoproliferative disorders after methotrexate therapy. J Med Cases. 2023, 14:282-8. 10.14740\/jmc4135","journal-title":"J Med Cases"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3348\/jksr.2012.67.2.109","article-title":"Rupture of hepatocellular carcinoma following transcatheter arterial chemoembolization: a case report","volume":"67","author":"Kang HJ","year":"2012","unstructured":"Kang HJ, Lee BH, Han YH, et al.. Rupture of hepatocellular carcinoma following transcatheter arterial chemoembolization: a case report. J Korean Soc Radiol. 2012, 67:109-12. 10.3348\/jksr.2012.67.2.109","journal-title":"J Korean Soc Radiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2012.12.006","article-title":"Ruptured hepatic carcinoma after transcatheter arterial chemoembolization","volume":"74","author":"Jia Z","year":"2013","unstructured":"Jia Z, Tian F, Jiang G. Ruptured hepatic carcinoma after transcatheter arterial chemoembolization. Curr Ther Res Clin Exp. 2013, 74:41-3. 10.1016\/j.curtheres.2012.12.006","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31407","article-title":"Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions","volume":"143","author":"Calip GS","year":"2018","unstructured":"Calip GS, Patel PR, Adimadhyam S, et al.. Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions. Int J Cancer. 2018, 143:1062-71. 10.1002\/ijc.31407","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092510","article-title":"The effects of biologics on hematologic malignancy development in patients with ankylosing spondylitis, psoriasis, or psoriatic arthritis: a national cohort study","volume":"11","author":"Tsai CJ","year":"2023","unstructured":"Tsai CJ, Lin YC, Chen CY, Hung CH, Lin YC. The effects of biologics on hematologic malignancy development in patients with ankylosing spondylitis, psoriasis, or psoriatic arthritis: a national cohort study. Biomedicines. 2023, 11:2510. 10.3390\/biomedicines11092510","journal-title":"Biomedicines"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.6520","article-title":"CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"34","author":"Schmitz N","year":"2016","unstructured":"Schmitz N, Zeynalova S, Nickelsen M, et al.. CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2016, 34:3150-6. 10.1200\/JCO.2015.65.6520","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/234926-hepatic-tumor-rupture-in-other-iatrogenic-immunodeficiency-associated-lymphoproliferative-disorders-of-the-b-cell-type-in-a-patient-with-chronic-rheumatoid-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:08:10Z","timestamp":1711012090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/234926-hepatic-tumor-rupture-in-other-iatrogenic-immunodeficiency-associated-lymphoproliferative-disorders-of-the-b-cell-type-in-a-patient-with-chronic-rheumatoid-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.56615","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,21]]}}}